APA Alıntı

Bassères, D. S., Ebbs, A., Cogswell, P. C., & Baldwin, A. S. (2014). IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity. Impact Journals LLC.

Chicago Stili Alıntı

Bassères, Daniela S., Aaron Ebbs, Patricia C. Cogswell, ve Albert S. Baldwin. IKK Is a Therapeutic Target in KRAS-Induced Lung Cancer With Disrupted P53 Activity. Impact Journals LLC, 2014.

MLA Alıntı

Bassères, Daniela S., Aaron Ebbs, Patricia C. Cogswell, ve Albert S. Baldwin. IKK Is a Therapeutic Target in KRAS-Induced Lung Cancer With Disrupted P53 Activity. Impact Journals LLC, 2014.